
Keywords: BTHS, Barth syndrome; CDP-DAG, cytidinediphosphate-diacylglycerol; CL, cardiolipin; MLCL, monolysocardiolipin; PC, phosphatidylcholine; PG, phosphatidylglycerol; TAZ, tafazzinTafazzin; Cardiolipin; Barth syndrome; Splice variant; Tissue distribution; Quan